ST1902-3

N/A

Report date: 2022/01/05 15:24:33
NME

Base Information

Drug NameST1902-3
Drug Alias NameST1902-3
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKappa opioid receptor antagonists
TargetsKappa opioid receptor
Therapy Area/IndicationsArthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Sunshine Novo Pharmaceutical Research Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Sunshine Novo Pharmaceutical Research Co Ltd
Inactive CompaniesN/A
Active IndicationsArthritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A